SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign Up For Weekly Top Stories

 

More Industry Headlines

Cigna revises policy to cover 3-D mammo for breast cancer screening Change credited to new NCCN guidance

Virginia Governer McAuliffe lauds focused ultrasound during foundation visit State invested $7 million in UVA focused ultrasound center

Hologic’s C-View software preserves clinical performance of 3-D mammo at lower dose Comparable detection and recall rates

This Month in Medical History – WHO declares H1N1 pandemic stopped August 2010 we closed the book on the outbreak of the so-called 'swine flu'

More Pseudomonas found at Prince George's Hospital Maryland facility investigating link between fatalities and deadly bacteria

Joint Commission presents clinical engineering survey updates and advice at CEAI Emphasizes new accreditation matrix and hand hygiene

Researchers propose bundled payment model for mammography Aligning incentives through mammo's established practice parameters

Wearable PET helmet may allow for imaging patients in motion Uses one-tenth of the conventional PET radiation dose

Yearly low-dose CT lung cancer screening is important for those at high risk Those with initial negative tests have higher mortality rates 1 and 2 years later

Most U.S. citizens would participate in precision medicine initiative: survey Young, educated people in particular

Bracco gets FDA nod to expand Multihance indications

by Brendon Nafziger , DOTmed News Associate Editor
Bracco Diagnostics Inc. said Friday it received Food and Drug Administration approval to expand the indications of an MRI imaging agent used to detect brain tumors to now cover certain types of arterial disease.

Bracco said the drug, Multihance (gadobenate dimeglumine), now has been expanded for use in magnetic resonance angiographies to help diagnose stenosis in the renal and aorto-ilio-femoral arteries. The gadolinium-based contrast agent was originally approved by the FDA in 2004 for MRI scans of the central nervous system in children and adults.

Story Continues Below Advertisement

What's the best path to the future of better health? YOURS.

The best way to navigate the evolving healthcare landscape is on a clear path. McKesson’s customizable solutions for radiology & cardiology are scalable to suit your exact size and complexity and provide standards-based integrations.Click for more info



The company said the approval came about after Bracco conducted two large, multi-center, prospective trials on the new indication.

As with other GBCAs, Multihance carries a black box warning label because of the risk of nephrogenic systemic fibrosis, believed to be an extremely rare side effect for patients with kidney problems who receive GBCA injections. However, in a statement, Dr. Alberto Spinazzi, senior vice president of regulatory affairs with Bracco, said Multihance carries a "strong record of safety" and has been administered more than 14 million times.

"Multihance has long been distinguished in the MRI of the CNS as a gadolinium-based contrast agent characterized by a strong increase in relaxivity in any medium containing serum proteins, contributing to increased contrast-to-noise ratio and lesion-to-brain ratio and improved visualization," he said.

Bracco Group is headquartered in Milan, Italy.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.
ALL RIGHTS RESERVED